nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP2A6—Progesterone—uterine cancer	0.17	0.466	CbGbCtD
Sevoflurane—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0515	0.141	CbGbCtD
Sevoflurane—CYP2E1—Etoposide—uterine cancer	0.0503	0.138	CbGbCtD
Sevoflurane—CYP3A4—Progesterone—uterine cancer	0.0341	0.0932	CbGbCtD
Sevoflurane—CYP2B6—Doxorubicin—uterine cancer	0.0339	0.0926	CbGbCtD
Sevoflurane—ND1—oviduct—uterine cancer	0.0166	0.0883	CbGeAlD
Sevoflurane—CYP3A4—Etoposide—uterine cancer	0.0153	0.0417	CbGbCtD
Sevoflurane—CYP3A4—Doxorubicin—uterine cancer	0.0104	0.0284	CbGbCtD
Sevoflurane—ND1—exocrine gland—uterine cancer	0.00956	0.0509	CbGeAlD
Sevoflurane—KCNK10—renal system—uterine cancer	0.00616	0.0329	CbGeAlD
Sevoflurane—KCNK3—renal system—uterine cancer	0.00556	0.0297	CbGeAlD
Sevoflurane—KCNK3—female reproductive system—uterine cancer	0.00446	0.0238	CbGeAlD
Sevoflurane—ATP5D—myometrium—uterine cancer	0.00427	0.0228	CbGeAlD
Sevoflurane—ATP2C1—myometrium—uterine cancer	0.00421	0.0225	CbGeAlD
Sevoflurane—KCNK2—vagina—uterine cancer	0.00417	0.0222	CbGeAlD
Sevoflurane—ND1—smooth muscle tissue—uterine cancer	0.00401	0.0214	CbGeAlD
Sevoflurane—ND1—renal system—uterine cancer	0.00386	0.0206	CbGeAlD
Sevoflurane—ATP5D—uterine cervix—uterine cancer	0.00332	0.0177	CbGeAlD
Sevoflurane—ATP2C1—uterine cervix—uterine cancer	0.00328	0.0175	CbGeAlD
Sevoflurane—ATP5D—smooth muscle tissue—uterine cancer	0.00323	0.0172	CbGeAlD
Sevoflurane—GABRP—uterine cervix—uterine cancer	0.00321	0.0171	CbGeAlD
Sevoflurane—ATP2C1—smooth muscle tissue—uterine cancer	0.00319	0.017	CbGeAlD
Sevoflurane—ATP5D—decidua—uterine cancer	0.00317	0.0169	CbGeAlD
Sevoflurane—GABRE—myometrium—uterine cancer	0.00315	0.0168	CbGeAlD
Sevoflurane—ATP2C1—decidua—uterine cancer	0.00312	0.0167	CbGeAlD
Sevoflurane—ATP5D—renal system—uterine cancer	0.00311	0.0166	CbGeAlD
Sevoflurane—ND1—female reproductive system—uterine cancer	0.00309	0.0165	CbGeAlD
Sevoflurane—ATP2C1—renal system—uterine cancer	0.00307	0.0164	CbGeAlD
Sevoflurane—GABRP—decidua—uterine cancer	0.00306	0.0163	CbGeAlD
Sevoflurane—ATP5D—endometrium—uterine cancer	0.00301	0.016	CbGeAlD
Sevoflurane—ATP2C1—endometrium—uterine cancer	0.00297	0.0158	CbGeAlD
Sevoflurane—GABRP—endometrium—uterine cancer	0.00291	0.0155	CbGeAlD
Sevoflurane—ATP5D—mammalian vulva—uterine cancer	0.00291	0.0155	CbGeAlD
Sevoflurane—ATP2C1—mammalian vulva—uterine cancer	0.00287	0.0153	CbGeAlD
Sevoflurane—GABRA4—mammalian vulva—uterine cancer	0.00283	0.0151	CbGeAlD
Sevoflurane—ND1—female gonad—uterine cancer	0.00281	0.015	CbGeAlD
Sevoflurane—ATP5D—uterus—uterine cancer	0.00277	0.0148	CbGeAlD
Sevoflurane—ATP2C1—uterus—uterine cancer	0.00273	0.0146	CbGeAlD
Sevoflurane—KCNK2—lymph node—uterine cancer	0.0027	0.0144	CbGeAlD
Sevoflurane—GABRP—uterus—uterine cancer	0.00268	0.0143	CbGeAlD
Sevoflurane—ATP5D—female reproductive system—uterine cancer	0.00249	0.0133	CbGeAlD
Sevoflurane—ATP2C1—female reproductive system—uterine cancer	0.00246	0.0131	CbGeAlD
Sevoflurane—GABRE—uterine cervix—uterine cancer	0.00245	0.0131	CbGeAlD
Sevoflurane—GABRB1—vagina—uterine cancer	0.00243	0.013	CbGeAlD
Sevoflurane—GABRP—female reproductive system—uterine cancer	0.00241	0.0128	CbGeAlD
Sevoflurane—GABRE—decidua—uterine cancer	0.00234	0.0125	CbGeAlD
Sevoflurane—ATP5D—female gonad—uterine cancer	0.00227	0.0121	CbGeAlD
Sevoflurane—ATP5D—vagina—uterine cancer	0.00225	0.012	CbGeAlD
Sevoflurane—ATP2C1—female gonad—uterine cancer	0.00224	0.0119	CbGeAlD
Sevoflurane—ATP2C1—vagina—uterine cancer	0.00222	0.0118	CbGeAlD
Sevoflurane—GABRE—endometrium—uterine cancer	0.00222	0.0118	CbGeAlD
Sevoflurane—GABRP—vagina—uterine cancer	0.00218	0.0116	CbGeAlD
Sevoflurane—GABRE—mammalian vulva—uterine cancer	0.00215	0.0114	CbGeAlD
Sevoflurane—CYP2A6—vagina—uterine cancer	0.0019	0.0101	CbGeAlD
Sevoflurane—GABRE—female reproductive system—uterine cancer	0.00184	0.0098	CbGeAlD
Sevoflurane—ND1—lymph node—uterine cancer	0.00181	0.00963	CbGeAlD
Sevoflurane—GABRA2—vagina—uterine cancer	0.00168	0.00894	CbGeAlD
Sevoflurane—GABRE—female gonad—uterine cancer	0.00167	0.00892	CbGeAlD
Sevoflurane—GABRE—vagina—uterine cancer	0.00166	0.00886	CbGeAlD
Sevoflurane—GABRB3—female reproductive system—uterine cancer	0.00156	0.00831	CbGeAlD
Sevoflurane—ATP5D—lymph node—uterine cancer	0.00146	0.00776	CbGeAlD
Sevoflurane—ATP2C1—lymph node—uterine cancer	0.00144	0.00766	CbGeAlD
Sevoflurane—CYP2B6—renal system—uterine cancer	0.00132	0.00703	CbGeAlD
Sevoflurane—Hypotension—Progesterone—uterine cancer	0.00125	0.00318	CcSEcCtD
Sevoflurane—CYP2E1—renal system—uterine cancer	0.00124	0.0066	CbGeAlD
Sevoflurane—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00315	CcSEcCtD
Sevoflurane—Glycosuria—Doxorubicin—uterine cancer	0.00123	0.00312	CcSEcCtD
Sevoflurane—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00311	CcSEcCtD
Sevoflurane—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00308	CcSEcCtD
Sevoflurane—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00308	CcSEcCtD
Sevoflurane—Insomnia—Progesterone—uterine cancer	0.00121	0.00308	CcSEcCtD
Sevoflurane—Chills—Dactinomycin—uterine cancer	0.00119	0.00304	CcSEcCtD
Sevoflurane—Dyspnoea—Progesterone—uterine cancer	0.00119	0.00303	CcSEcCtD
Sevoflurane—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00303	CcSEcCtD
Sevoflurane—Ventricular extrasystoles—Epirubicin—uterine cancer	0.00119	0.00303	CcSEcCtD
Sevoflurane—Bone disorder—Epirubicin—uterine cancer	0.00119	0.00303	CcSEcCtD
Sevoflurane—Somnolence—Progesterone—uterine cancer	0.00119	0.00303	CcSEcCtD
Sevoflurane—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00302	CcSEcCtD
Sevoflurane—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00302	CcSEcCtD
Sevoflurane—Bronchospasm—Etoposide—uterine cancer	0.00118	0.00301	CcSEcCtD
Sevoflurane—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00301	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Epirubicin—uterine cancer	0.00118	0.00301	CcSEcCtD
Sevoflurane—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.003	CcSEcCtD
Sevoflurane—Cough increased—Epirubicin—uterine cancer	0.00117	0.00299	CcSEcCtD
Sevoflurane—Oliguria—Epirubicin—uterine cancer	0.00116	0.00297	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Progesterone—uterine cancer	0.00115	0.00294	CcSEcCtD
Sevoflurane—Pain—Progesterone—uterine cancer	0.00114	0.00291	CcSEcCtD
Sevoflurane—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00288	CcSEcCtD
Sevoflurane—Feeling abnormal—Progesterone—uterine cancer	0.0011	0.0028	CcSEcCtD
Sevoflurane—Ventricular extrasystoles—Doxorubicin—uterine cancer	0.0011	0.0028	CcSEcCtD
Sevoflurane—Bone disorder—Doxorubicin—uterine cancer	0.0011	0.0028	CcSEcCtD
Sevoflurane—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00279	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Doxorubicin—uterine cancer	0.00109	0.00278	CcSEcCtD
Sevoflurane—GABRA2—lymph node—uterine cancer	0.00108	0.00578	CbGeAlD
Sevoflurane—Cough increased—Doxorubicin—uterine cancer	0.00108	0.00276	CcSEcCtD
Sevoflurane—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00275	CcSEcCtD
Sevoflurane—Oliguria—Doxorubicin—uterine cancer	0.00108	0.00275	CcSEcCtD
Sevoflurane—GABRE—lymph node—uterine cancer	0.00108	0.00573	CbGeAlD
Sevoflurane—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00274	CcSEcCtD
Sevoflurane—Ventricular tachycardia—Epirubicin—uterine cancer	0.00107	0.00274	CcSEcCtD
Sevoflurane—Hiccups—Epirubicin—uterine cancer	0.00107	0.00274	CcSEcCtD
Sevoflurane—Urticaria—Progesterone—uterine cancer	0.00106	0.0027	CcSEcCtD
Sevoflurane—Dermatitis contact—Epirubicin—uterine cancer	0.00106	0.0027	CcSEcCtD
Sevoflurane—CYP2B6—female reproductive system—uterine cancer	0.00106	0.00563	CbGeAlD
Sevoflurane—Body temperature increased—Progesterone—uterine cancer	0.00106	0.00269	CcSEcCtD
Sevoflurane—Hyperkalaemia—Epirubicin—uterine cancer	0.00105	0.00269	CcSEcCtD
Sevoflurane—Renal failure—Etoposide—uterine cancer	0.00105	0.00268	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00266	CcSEcCtD
Sevoflurane—Jaundice—Etoposide—uterine cancer	0.00104	0.00266	CcSEcCtD
Sevoflurane—Salivary hypersecretion—Epirubicin—uterine cancer	0.00104	0.00266	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Etoposide—uterine cancer	0.00101	0.00258	CcSEcCtD
Sevoflurane—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000997	0.00254	CcSEcCtD
Sevoflurane—CYP3A4—renal system—uterine cancer	0.000996	0.00531	CbGeAlD
Sevoflurane—Ventricular tachycardia—Doxorubicin—uterine cancer	0.000993	0.00253	CcSEcCtD
Sevoflurane—Hiccups—Doxorubicin—uterine cancer	0.000993	0.00253	CcSEcCtD
Sevoflurane—CYP2E1—female reproductive system—uterine cancer	0.000992	0.00529	CbGeAlD
Sevoflurane—Hypersensitivity—Progesterone—uterine cancer	0.000984	0.00251	CcSEcCtD
Sevoflurane—Dermatitis contact—Doxorubicin—uterine cancer	0.000981	0.0025	CcSEcCtD
Sevoflurane—ALB—lymph node—uterine cancer	0.00098	0.00523	CbGeAlD
Sevoflurane—Hyperkalaemia—Doxorubicin—uterine cancer	0.000976	0.00249	CcSEcCtD
Sevoflurane—Salivary hypersecretion—Doxorubicin—uterine cancer	0.000964	0.00246	CcSEcCtD
Sevoflurane—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000961	0.00245	CcSEcCtD
Sevoflurane—Asthenia—Progesterone—uterine cancer	0.000958	0.00244	CcSEcCtD
Sevoflurane—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000956	0.00244	CcSEcCtD
Sevoflurane—CYP2B6—vagina—uterine cancer	0.000956	0.00509	CbGeAlD
Sevoflurane—Urinary tract disorder—Etoposide—uterine cancer	0.000949	0.00242	CcSEcCtD
Sevoflurane—Pruritus—Progesterone—uterine cancer	0.000945	0.00241	CcSEcCtD
Sevoflurane—Oedema—Dactinomycin—uterine cancer	0.000944	0.00241	CcSEcCtD
Sevoflurane—Urethral disorder—Etoposide—uterine cancer	0.000942	0.0024	CcSEcCtD
Sevoflurane—Hypertonia—Epirubicin—uterine cancer	0.000941	0.0024	CcSEcCtD
Sevoflurane—Thrombocytopenia—Dactinomycin—uterine cancer	0.000924	0.00236	CcSEcCtD
Sevoflurane—Cardiac disorder—Etoposide—uterine cancer	0.000892	0.00227	CcSEcCtD
Sevoflurane—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000891	0.00227	CcSEcCtD
Sevoflurane—Hepatic function abnormal—Epirubicin—uterine cancer	0.000891	0.00227	CcSEcCtD
Sevoflurane—Dizziness—Progesterone—uterine cancer	0.000883	0.00225	CcSEcCtD
Sevoflurane—Angiopathy—Etoposide—uterine cancer	0.000872	0.00222	CcSEcCtD
Sevoflurane—Hypertonia—Doxorubicin—uterine cancer	0.00087	0.00222	CcSEcCtD
Sevoflurane—Immune system disorder—Etoposide—uterine cancer	0.000868	0.00221	CcSEcCtD
Sevoflurane—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000868	0.00221	CcSEcCtD
Sevoflurane—Hepatic failure—Epirubicin—uterine cancer	0.000867	0.00221	CcSEcCtD
Sevoflurane—Mediastinal disorder—Etoposide—uterine cancer	0.000866	0.00221	CcSEcCtD
Sevoflurane—Chills—Etoposide—uterine cancer	0.000863	0.0022	CcSEcCtD
Sevoflurane—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000856	0.00218	CcSEcCtD
Sevoflurane—Vomiting—Progesterone—uterine cancer	0.000849	0.00216	CcSEcCtD
Sevoflurane—Renal failure acute—Epirubicin—uterine cancer	0.000844	0.00215	CcSEcCtD
Sevoflurane—Rash—Progesterone—uterine cancer	0.000842	0.00215	CcSEcCtD
Sevoflurane—Dermatitis—Progesterone—uterine cancer	0.000841	0.00214	CcSEcCtD
Sevoflurane—Headache—Progesterone—uterine cancer	0.000836	0.00213	CcSEcCtD
Sevoflurane—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000825	0.0021	CcSEcCtD
Sevoflurane—Dysgeusia—Etoposide—uterine cancer	0.00082	0.00209	CcSEcCtD
Sevoflurane—Pain—Dactinomycin—uterine cancer	0.000807	0.00206	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000805	0.00205	CcSEcCtD
Sevoflurane—Hepatic failure—Doxorubicin—uterine cancer	0.000802	0.00204	CcSEcCtD
Sevoflurane—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0008	0.00204	CcSEcCtD
Sevoflurane—CYP3A4—female reproductive system—uterine cancer	0.000798	0.00425	CbGeAlD
Sevoflurane—Nausea—Progesterone—uterine cancer	0.000793	0.00202	CcSEcCtD
Sevoflurane—Renal failure acute—Doxorubicin—uterine cancer	0.000781	0.00199	CcSEcCtD
Sevoflurane—Feeling abnormal—Dactinomycin—uterine cancer	0.000778	0.00198	CcSEcCtD
Sevoflurane—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000769	0.00196	CcSEcCtD
Sevoflurane—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000763	0.00194	CcSEcCtD
Sevoflurane—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000762	0.00194	CcSEcCtD
Sevoflurane—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000758	0.00193	CcSEcCtD
Sevoflurane—Body temperature increased—Dactinomycin—uterine cancer	0.000746	0.0019	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000745	0.0019	CcSEcCtD
Sevoflurane—Cardiac arrest—Epirubicin—uterine cancer	0.000741	0.00189	CcSEcCtD
Sevoflurane—Loss of consciousness—Etoposide—uterine cancer	0.000736	0.00187	CcSEcCtD
Sevoflurane—Cough—Etoposide—uterine cancer	0.00073	0.00186	CcSEcCtD
Sevoflurane—Convulsion—Etoposide—uterine cancer	0.000725	0.00185	CcSEcCtD
Sevoflurane—Hypertension—Etoposide—uterine cancer	0.000723	0.00184	CcSEcCtD
Sevoflurane—Liver function test abnormal—Epirubicin—uterine cancer	0.000719	0.00183	CcSEcCtD
Sevoflurane—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000719	0.00183	CcSEcCtD
Sevoflurane—Chest pain—Etoposide—uterine cancer	0.000712	0.00182	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000708	0.0018	CcSEcCtD
Sevoflurane—Hypersensitivity—Dactinomycin—uterine cancer	0.000695	0.00177	CcSEcCtD
Sevoflurane—Confusional state—Etoposide—uterine cancer	0.000689	0.00176	CcSEcCtD
Sevoflurane—Cardiac arrest—Doxorubicin—uterine cancer	0.000685	0.00175	CcSEcCtD
Sevoflurane—Anaphylactic shock—Etoposide—uterine cancer	0.000683	0.00174	CcSEcCtD
Sevoflurane—Asthenia—Dactinomycin—uterine cancer	0.000677	0.00173	CcSEcCtD
Sevoflurane—Thrombocytopenia—Etoposide—uterine cancer	0.000669	0.0017	CcSEcCtD
Sevoflurane—Tachycardia—Etoposide—uterine cancer	0.000667	0.0017	CcSEcCtD
Sevoflurane—Liver function test abnormal—Doxorubicin—uterine cancer	0.000665	0.0017	CcSEcCtD
Sevoflurane—Skin disorder—Etoposide—uterine cancer	0.000663	0.00169	CcSEcCtD
Sevoflurane—Pancreatitis—Epirubicin—uterine cancer	0.00066	0.00168	CcSEcCtD
Sevoflurane—Hypotension—Etoposide—uterine cancer	0.000638	0.00163	CcSEcCtD
Sevoflurane—Dysuria—Epirubicin—uterine cancer	0.00063	0.0016	CcSEcCtD
Sevoflurane—Pancreatitis—Doxorubicin—uterine cancer	0.000611	0.00156	CcSEcCtD
Sevoflurane—Dyspnoea—Etoposide—uterine cancer	0.000609	0.00155	CcSEcCtD
Sevoflurane—Hyperglycaemia—Epirubicin—uterine cancer	0.000607	0.00155	CcSEcCtD
Sevoflurane—Somnolence—Etoposide—uterine cancer	0.000607	0.00155	CcSEcCtD
Sevoflurane—Vomiting—Dactinomycin—uterine cancer	0.0006	0.00153	CcSEcCtD
Sevoflurane—Rash—Dactinomycin—uterine cancer	0.000595	0.00152	CcSEcCtD
Sevoflurane—Renal failure—Epirubicin—uterine cancer	0.00059	0.0015	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Etoposide—uterine cancer	0.00059	0.0015	CcSEcCtD
Sevoflurane—Jaundice—Epirubicin—uterine cancer	0.000585	0.00149	CcSEcCtD
Sevoflurane—Pain—Etoposide—uterine cancer	0.000584	0.00149	CcSEcCtD
Sevoflurane—Conjunctivitis—Epirubicin—uterine cancer	0.000583	0.00149	CcSEcCtD
Sevoflurane—Dysuria—Doxorubicin—uterine cancer	0.000582	0.00148	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Epirubicin—uterine cancer	0.000568	0.00145	CcSEcCtD
Sevoflurane—Feeling abnormal—Etoposide—uterine cancer	0.000563	0.00143	CcSEcCtD
Sevoflurane—Hyperglycaemia—Doxorubicin—uterine cancer	0.000562	0.00143	CcSEcCtD
Sevoflurane—Nausea—Dactinomycin—uterine cancer	0.000561	0.00143	CcSEcCtD
Sevoflurane—Bradycardia—Epirubicin—uterine cancer	0.000549	0.0014	CcSEcCtD
Sevoflurane—Renal failure—Doxorubicin—uterine cancer	0.000546	0.00139	CcSEcCtD
Sevoflurane—Urticaria—Etoposide—uterine cancer	0.000543	0.00138	CcSEcCtD
Sevoflurane—Haemoglobin—Epirubicin—uterine cancer	0.000542	0.00138	CcSEcCtD
Sevoflurane—Jaundice—Doxorubicin—uterine cancer	0.000541	0.00138	CcSEcCtD
Sevoflurane—Body temperature increased—Etoposide—uterine cancer	0.00054	0.00138	CcSEcCtD
Sevoflurane—Conjunctivitis—Doxorubicin—uterine cancer	0.00054	0.00138	CcSEcCtD
Sevoflurane—Haemorrhage—Epirubicin—uterine cancer	0.000539	0.00137	CcSEcCtD
Sevoflurane—Hepatitis—Epirubicin—uterine cancer	0.000539	0.00137	CcSEcCtD
Sevoflurane—Pharyngitis—Epirubicin—uterine cancer	0.000535	0.00136	CcSEcCtD
Sevoflurane—Urinary tract disorder—Epirubicin—uterine cancer	0.000532	0.00136	CcSEcCtD
Sevoflurane—Urethral disorder—Epirubicin—uterine cancer	0.000528	0.00135	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000525	0.00134	CcSEcCtD
Sevoflurane—Bradycardia—Doxorubicin—uterine cancer	0.000508	0.00129	CcSEcCtD
Sevoflurane—Hypersensitivity—Etoposide—uterine cancer	0.000503	0.00128	CcSEcCtD
Sevoflurane—Haemoglobin—Doxorubicin—uterine cancer	0.000501	0.00128	CcSEcCtD
Sevoflurane—Cardiac disorder—Epirubicin—uterine cancer	0.0005	0.00127	CcSEcCtD
Sevoflurane—Haemorrhage—Doxorubicin—uterine cancer	0.000499	0.00127	CcSEcCtD
Sevoflurane—Hepatitis—Doxorubicin—uterine cancer	0.000499	0.00127	CcSEcCtD
Sevoflurane—Pharyngitis—Doxorubicin—uterine cancer	0.000495	0.00126	CcSEcCtD
Sevoflurane—Urinary tract disorder—Doxorubicin—uterine cancer	0.000492	0.00126	CcSEcCtD
Sevoflurane—Asthenia—Etoposide—uterine cancer	0.00049	0.00125	CcSEcCtD
Sevoflurane—Angiopathy—Epirubicin—uterine cancer	0.000489	0.00125	CcSEcCtD
Sevoflurane—Urethral disorder—Doxorubicin—uterine cancer	0.000489	0.00125	CcSEcCtD
Sevoflurane—Immune system disorder—Epirubicin—uterine cancer	0.000487	0.00124	CcSEcCtD
Sevoflurane—Mediastinal disorder—Epirubicin—uterine cancer	0.000486	0.00124	CcSEcCtD
Sevoflurane—Chills—Epirubicin—uterine cancer	0.000484	0.00123	CcSEcCtD
Sevoflurane—Pruritus—Etoposide—uterine cancer	0.000483	0.00123	CcSEcCtD
Sevoflurane—Arrhythmia—Epirubicin—uterine cancer	0.000481	0.00123	CcSEcCtD
Sevoflurane—Mental disorder—Epirubicin—uterine cancer	0.000472	0.0012	CcSEcCtD
Sevoflurane—Malnutrition—Epirubicin—uterine cancer	0.000469	0.0012	CcSEcCtD
Sevoflurane—Cardiac disorder—Doxorubicin—uterine cancer	0.000463	0.00118	CcSEcCtD
Sevoflurane—Tension—Epirubicin—uterine cancer	0.00046	0.00117	CcSEcCtD
Sevoflurane—Dysgeusia—Epirubicin—uterine cancer	0.000459	0.00117	CcSEcCtD
Sevoflurane—Nervousness—Epirubicin—uterine cancer	0.000456	0.00116	CcSEcCtD
Sevoflurane—Angiopathy—Doxorubicin—uterine cancer	0.000452	0.00115	CcSEcCtD
Sevoflurane—Dizziness—Etoposide—uterine cancer	0.000452	0.00115	CcSEcCtD
Sevoflurane—Immune system disorder—Doxorubicin—uterine cancer	0.00045	0.00115	CcSEcCtD
Sevoflurane—Mediastinal disorder—Doxorubicin—uterine cancer	0.000449	0.00115	CcSEcCtD
Sevoflurane—Chills—Doxorubicin—uterine cancer	0.000447	0.00114	CcSEcCtD
Sevoflurane—Arrhythmia—Doxorubicin—uterine cancer	0.000445	0.00114	CcSEcCtD
Sevoflurane—Mental disorder—Doxorubicin—uterine cancer	0.000437	0.00111	CcSEcCtD
Sevoflurane—Vomiting—Etoposide—uterine cancer	0.000434	0.00111	CcSEcCtD
Sevoflurane—Malnutrition—Doxorubicin—uterine cancer	0.000434	0.00111	CcSEcCtD
Sevoflurane—Agitation—Epirubicin—uterine cancer	0.000431	0.0011	CcSEcCtD
Sevoflurane—Rash—Etoposide—uterine cancer	0.000431	0.0011	CcSEcCtD
Sevoflurane—Dermatitis—Etoposide—uterine cancer	0.00043	0.0011	CcSEcCtD
Sevoflurane—Headache—Etoposide—uterine cancer	0.000428	0.00109	CcSEcCtD
Sevoflurane—Tension—Doxorubicin—uterine cancer	0.000426	0.00109	CcSEcCtD
Sevoflurane—Dysgeusia—Doxorubicin—uterine cancer	0.000425	0.00108	CcSEcCtD
Sevoflurane—Nervousness—Doxorubicin—uterine cancer	0.000422	0.00107	CcSEcCtD
Sevoflurane—Syncope—Epirubicin—uterine cancer	0.000421	0.00107	CcSEcCtD
Sevoflurane—Loss of consciousness—Epirubicin—uterine cancer	0.000412	0.00105	CcSEcCtD
Sevoflurane—Cough—Epirubicin—uterine cancer	0.000409	0.00104	CcSEcCtD
Sevoflurane—Convulsion—Epirubicin—uterine cancer	0.000406	0.00104	CcSEcCtD
Sevoflurane—Nausea—Etoposide—uterine cancer	0.000406	0.00103	CcSEcCtD
Sevoflurane—Hypertension—Epirubicin—uterine cancer	0.000405	0.00103	CcSEcCtD
Sevoflurane—Chest pain—Epirubicin—uterine cancer	0.000399	0.00102	CcSEcCtD
Sevoflurane—Agitation—Doxorubicin—uterine cancer	0.000399	0.00102	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000397	0.00101	CcSEcCtD
Sevoflurane—Dry mouth—Epirubicin—uterine cancer	0.000391	0.000996	CcSEcCtD
Sevoflurane—Syncope—Doxorubicin—uterine cancer	0.000389	0.000992	CcSEcCtD
Sevoflurane—Confusional state—Epirubicin—uterine cancer	0.000386	0.000984	CcSEcCtD
Sevoflurane—Anaphylactic shock—Epirubicin—uterine cancer	0.000383	0.000976	CcSEcCtD
Sevoflurane—Oedema—Epirubicin—uterine cancer	0.000383	0.000976	CcSEcCtD
Sevoflurane—Loss of consciousness—Doxorubicin—uterine cancer	0.000381	0.000972	CcSEcCtD
Sevoflurane—Cough—Doxorubicin—uterine cancer	0.000379	0.000965	CcSEcCtD
Sevoflurane—Shock—Epirubicin—uterine cancer	0.000377	0.00096	CcSEcCtD
Sevoflurane—Convulsion—Doxorubicin—uterine cancer	0.000376	0.000959	CcSEcCtD
Sevoflurane—Nervous system disorder—Epirubicin—uterine cancer	0.000375	0.000957	CcSEcCtD
Sevoflurane—Thrombocytopenia—Epirubicin—uterine cancer	0.000375	0.000955	CcSEcCtD
Sevoflurane—Hypertension—Doxorubicin—uterine cancer	0.000375	0.000955	CcSEcCtD
Sevoflurane—Tachycardia—Epirubicin—uterine cancer	0.000374	0.000952	CcSEcCtD
Sevoflurane—Skin disorder—Epirubicin—uterine cancer	0.000372	0.000948	CcSEcCtD
Sevoflurane—Chest pain—Doxorubicin—uterine cancer	0.00037	0.000942	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000367	0.000935	CcSEcCtD
Sevoflurane—Dry mouth—Doxorubicin—uterine cancer	0.000361	0.000921	CcSEcCtD
Sevoflurane—Hypotension—Epirubicin—uterine cancer	0.000358	0.000912	CcSEcCtD
Sevoflurane—Confusional state—Doxorubicin—uterine cancer	0.000357	0.00091	CcSEcCtD
Sevoflurane—Oedema—Doxorubicin—uterine cancer	0.000354	0.000903	CcSEcCtD
Sevoflurane—Anaphylactic shock—Doxorubicin—uterine cancer	0.000354	0.000903	CcSEcCtD
Sevoflurane—Shock—Doxorubicin—uterine cancer	0.000349	0.000888	CcSEcCtD
Sevoflurane—Nervous system disorder—Doxorubicin—uterine cancer	0.000347	0.000885	CcSEcCtD
Sevoflurane—Thrombocytopenia—Doxorubicin—uterine cancer	0.000347	0.000884	CcSEcCtD
Sevoflurane—Insomnia—Epirubicin—uterine cancer	0.000346	0.000883	CcSEcCtD
Sevoflurane—Tachycardia—Doxorubicin—uterine cancer	0.000346	0.000881	CcSEcCtD
Sevoflurane—Skin disorder—Doxorubicin—uterine cancer	0.000344	0.000877	CcSEcCtD
Sevoflurane—Dyspnoea—Epirubicin—uterine cancer	0.000341	0.00087	CcSEcCtD
Sevoflurane—Somnolence—Epirubicin—uterine cancer	0.00034	0.000868	CcSEcCtD
Sevoflurane—Hypotension—Doxorubicin—uterine cancer	0.000331	0.000844	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000331	0.000842	CcSEcCtD
Sevoflurane—Pain—Epirubicin—uterine cancer	0.000327	0.000834	CcSEcCtD
Sevoflurane—Insomnia—Doxorubicin—uterine cancer	0.00032	0.000817	CcSEcCtD
Sevoflurane—Dyspnoea—Doxorubicin—uterine cancer	0.000316	0.000805	CcSEcCtD
Sevoflurane—Feeling abnormal—Epirubicin—uterine cancer	0.000315	0.000804	CcSEcCtD
Sevoflurane—Somnolence—Doxorubicin—uterine cancer	0.000315	0.000803	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000306	0.00078	CcSEcCtD
Sevoflurane—Urticaria—Epirubicin—uterine cancer	0.000304	0.000775	CcSEcCtD
Sevoflurane—Pain—Doxorubicin—uterine cancer	0.000303	0.000772	CcSEcCtD
Sevoflurane—Body temperature increased—Epirubicin—uterine cancer	0.000303	0.000771	CcSEcCtD
Sevoflurane—Feeling abnormal—Doxorubicin—uterine cancer	0.000292	0.000744	CcSEcCtD
Sevoflurane—Hypersensitivity—Epirubicin—uterine cancer	0.000282	0.000719	CcSEcCtD
Sevoflurane—Urticaria—Doxorubicin—uterine cancer	0.000281	0.000717	CcSEcCtD
Sevoflurane—Body temperature increased—Doxorubicin—uterine cancer	0.00028	0.000714	CcSEcCtD
Sevoflurane—Asthenia—Epirubicin—uterine cancer	0.000275	0.0007	CcSEcCtD
Sevoflurane—Pruritus—Epirubicin—uterine cancer	0.000271	0.00069	CcSEcCtD
Sevoflurane—Hypersensitivity—Doxorubicin—uterine cancer	0.000261	0.000665	CcSEcCtD
Sevoflurane—Asthenia—Doxorubicin—uterine cancer	0.000254	0.000648	CcSEcCtD
Sevoflurane—Dizziness—Epirubicin—uterine cancer	0.000253	0.000645	CcSEcCtD
Sevoflurane—Pruritus—Doxorubicin—uterine cancer	0.000251	0.000639	CcSEcCtD
Sevoflurane—Vomiting—Epirubicin—uterine cancer	0.000243	0.00062	CcSEcCtD
Sevoflurane—Rash—Epirubicin—uterine cancer	0.000241	0.000615	CcSEcCtD
Sevoflurane—Dermatitis—Epirubicin—uterine cancer	0.000241	0.000615	CcSEcCtD
Sevoflurane—Headache—Epirubicin—uterine cancer	0.00024	0.000611	CcSEcCtD
Sevoflurane—Dizziness—Doxorubicin—uterine cancer	0.000234	0.000597	CcSEcCtD
Sevoflurane—Nausea—Epirubicin—uterine cancer	0.000227	0.00058	CcSEcCtD
Sevoflurane—Vomiting—Doxorubicin—uterine cancer	0.000225	0.000574	CcSEcCtD
Sevoflurane—Rash—Doxorubicin—uterine cancer	0.000223	0.000569	CcSEcCtD
Sevoflurane—Dermatitis—Doxorubicin—uterine cancer	0.000223	0.000569	CcSEcCtD
Sevoflurane—Headache—Doxorubicin—uterine cancer	0.000222	0.000566	CcSEcCtD
Sevoflurane—Nausea—Doxorubicin—uterine cancer	0.00021	0.000536	CcSEcCtD
Sevoflurane—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.00016	0.00295	CbGpPWpGaD
Sevoflurane—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000157	0.00289	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000154	0.00284	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AKR1B1—uterine cancer	0.000153	0.00281	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—STAR—uterine cancer	0.000153	0.00281	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AKR1B1—uterine cancer	0.000153	0.00281	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—STAR—uterine cancer	0.000153	0.00281	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000152	0.0028	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—ESR2—uterine cancer	0.000149	0.00275	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—CTNNB1—uterine cancer	0.000147	0.00272	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000144	0.00265	CbGpPWpGaD
Sevoflurane—CYP2A6—Biological oxidations—CYP11A1—uterine cancer	0.000143	0.00264	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—MTHFR—uterine cancer	0.000142	0.00262	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000142	0.00262	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—AKR1C1—uterine cancer	0.00014	0.00258	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000137	0.00253	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00013	0.00239	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000126	0.00232	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000124	0.00228	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—GPX3—uterine cancer	0.000123	0.00226	CbGpPWpGaD
Sevoflurane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000122	0.00225	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000122	0.00224	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000121	0.00223	CbGpPWpGaD
Sevoflurane—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00012	0.00222	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—GPX3—uterine cancer	0.00012	0.00222	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—POLD1—uterine cancer	0.00012	0.00221	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—POLD1—uterine cancer	0.00012	0.00221	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000119	0.00219	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—MTHFR—uterine cancer	0.000116	0.00213	CbGpPWpGaD
Sevoflurane—CYP2B6—Biological oxidations—CYP11A1—uterine cancer	0.000116	0.00213	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—CYP11A1—uterine cancer	0.000114	0.0021	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—CYP11A1—uterine cancer	0.000113	0.00209	CbGpPWpGaD
Sevoflurane—CYP2A6—Fluoropyrimidine Activity—TP53—uterine cancer	0.000113	0.00208	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AKR1C1—uterine cancer	0.000112	0.00207	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AKR1C1—uterine cancer	0.000112	0.00207	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000112	0.00206	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—CCL2—uterine cancer	0.000111	0.00205	CbGpPWpGaD
Sevoflurane—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000111	0.00205	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—AKR1C3—uterine cancer	0.000108	0.00199	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000105	0.00194	CbGpPWpGaD
Sevoflurane—CYP2A6—Biological oxidations—CYP19A1—uterine cancer	0.000105	0.00194	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000104	0.00191	CbGpPWpGaD
Sevoflurane—KCNK18—Neuronal System—HRAS—uterine cancer	0.000103	0.00191	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—RRM2—uterine cancer	9.99e-05	0.00184	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—RRM2—uterine cancer	9.99e-05	0.00184	CbGpPWpGaD
Sevoflurane—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	9.89e-05	0.00182	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—DCN—uterine cancer	9.7e-05	0.00179	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—DCN—uterine cancer	9.7e-05	0.00179	CbGpPWpGaD
Sevoflurane—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	9.58e-05	0.00177	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—HRAS—uterine cancer	9.37e-05	0.00173	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	9.31e-05	0.00172	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—MTHFR—uterine cancer	9.2e-05	0.0017	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CYP11A1—uterine cancer	9.13e-05	0.00168	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CYP11A1—uterine cancer	9.13e-05	0.00168	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—CCL2—uterine cancer	9.06e-05	0.00167	CbGpPWpGaD
Sevoflurane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	8.97e-05	0.00165	CbGpPWpGaD
Sevoflurane—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	8.86e-05	0.00163	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	8.66e-05	0.0016	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.64e-05	0.00159	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AKR1C3—uterine cancer	8.63e-05	0.00159	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AKR1C3—uterine cancer	8.63e-05	0.00159	CbGpPWpGaD
Sevoflurane—CYP2B6—Biological oxidations—CYP19A1—uterine cancer	8.5e-05	0.00157	CbGpPWpGaD
Sevoflurane—KCNK10—Neuronal System—HRAS—uterine cancer	8.42e-05	0.00155	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—CYP19A1—uterine cancer	8.39e-05	0.00155	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	8.33e-05	0.00154	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—AKT1—uterine cancer	8.27e-05	0.00153	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	8.22e-05	0.00151	CbGpPWpGaD
Sevoflurane—KCNA1—Neuronal System—HRAS—uterine cancer	8.17e-05	0.00151	CbGpPWpGaD
Sevoflurane—KCNK2—Neuronal System—HRAS—uterine cancer	8.05e-05	0.00148	CbGpPWpGaD
Sevoflurane—KCNK9—Neuronal System—HRAS—uterine cancer	7.83e-05	0.00144	CbGpPWpGaD
Sevoflurane—KCNK3—Neuronal System—HRAS—uterine cancer	7.83e-05	0.00144	CbGpPWpGaD
Sevoflurane—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	7.28e-05	0.00134	CbGpPWpGaD
Sevoflurane—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	7.26e-05	0.00134	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—CTNNB1—uterine cancer	7.2e-05	0.00133	CbGpPWpGaD
Sevoflurane—GRIA1—Transmission across Chemical Synapses—HRAS—uterine cancer	7.2e-05	0.00133	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	7.2e-05	0.00133	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—STK11—uterine cancer	6.72e-05	0.00124	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—STK11—uterine cancer	6.72e-05	0.00124	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CYP19A1—uterine cancer	6.72e-05	0.00124	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CYP19A1—uterine cancer	6.72e-05	0.00124	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	6.36e-05	0.00117	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	6.29e-05	0.00116	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.25e-05	0.00115	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.25e-05	0.00115	CbGpPWpGaD
Sevoflurane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	5.98e-05	0.0011	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	5.94e-05	0.00109	CbGpPWpGaD
Sevoflurane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	5.89e-05	0.00109	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	5.8e-05	0.00107	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NDUFB11—uterine cancer	5.66e-05	0.00104	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SRD5A2—uterine cancer	5.66e-05	0.00104	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	5.58e-05	0.00103	CbGpPWpGaD
Sevoflurane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	5.57e-05	0.00103	CbGpPWpGaD
Sevoflurane—GRIA1—Neuronal System—HRAS—uterine cancer	5.52e-05	0.00102	CbGpPWpGaD
Sevoflurane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	5.5e-05	0.00101	CbGpPWpGaD
Sevoflurane—GABRQ—Transmission across Chemical Synapses—HRAS—uterine cancer	5.46e-05	0.00101	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—EP300—uterine cancer	5.39e-05	0.000994	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	5.25e-05	0.000969	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	5.18e-05	0.000955	CbGpPWpGaD
Sevoflurane—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	5.13e-05	0.000947	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	5.11e-05	0.000942	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—MTHFR—uterine cancer	5.05e-05	0.000931	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—MTHFR—uterine cancer	5.05e-05	0.000931	CbGpPWpGaD
Sevoflurane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	5.03e-05	0.000928	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—VEGFA—uterine cancer	4.99e-05	0.00092	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	4.89e-05	0.000902	CbGpPWpGaD
Sevoflurane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	4.89e-05	0.000902	CbGpPWpGaD
Sevoflurane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	4.8e-05	0.000885	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	4.75e-05	0.000876	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	4.72e-05	0.00087	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	4.69e-05	0.000864	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	4.6e-05	0.000849	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.58e-05	0.000845	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—HRAS—uterine cancer	4.58e-05	0.000845	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NDUFB11—uterine cancer	4.57e-05	0.000843	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SRD5A2—uterine cancer	4.57e-05	0.000843	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—HRAS—uterine cancer	4.49e-05	0.000829	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SRD5A2—uterine cancer	4.48e-05	0.000825	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NDUFB11—uterine cancer	4.48e-05	0.000825	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—HRAS—uterine cancer	4.43e-05	0.000816	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TP53—uterine cancer	4.4e-05	0.00081	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—HRAS—uterine cancer	4.19e-05	0.000773	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—HRAS—uterine cancer	4.18e-05	0.000771	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—HRAS—uterine cancer	4.14e-05	0.000763	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AKR1B1—uterine cancer	4.1e-05	0.000755	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—STAR—uterine cancer	4.1e-05	0.000755	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—AKT1—uterine cancer	4.05e-05	0.000746	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	4.02e-05	0.000742	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	3.86e-05	0.000713	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IRF1—uterine cancer	3.86e-05	0.000711	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SRD5A2—uterine cancer	3.85e-05	0.000709	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NDUFB11—uterine cancer	3.85e-05	0.000709	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	3.81e-05	0.000703	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—HRAS—uterine cancer	3.78e-05	0.000698	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.74e-05	0.000689	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—HRAS—uterine cancer	3.68e-05	0.000678	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—HRAS—uterine cancer	3.61e-05	0.000666	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—HRAS—uterine cancer	3.55e-05	0.000654	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.53e-05	0.000651	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—HRAS—uterine cancer	3.52e-05	0.00065	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—HRAS—uterine cancer	3.46e-05	0.000638	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—HRAS—uterine cancer	3.44e-05	0.000635	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—HRAS—uterine cancer	3.39e-05	0.000626	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKR1B1—uterine cancer	3.3e-05	0.000609	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—STAR—uterine cancer	3.3e-05	0.000609	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—STAR—uterine cancer	3.24e-05	0.000597	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKR1B1—uterine cancer	3.24e-05	0.000597	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—POLD1—uterine cancer	3.21e-05	0.000593	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—HRAS—uterine cancer	3.21e-05	0.000592	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—HRAS—uterine cancer	3.17e-05	0.000584	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—HRAS—uterine cancer	3.02e-05	0.000558	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AKR1C1—uterine cancer	3.01e-05	0.000554	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—HRAS—uterine cancer	2.9e-05	0.000535	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—HRAS—uterine cancer	2.82e-05	0.000519	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTEN—uterine cancer	2.81e-05	0.000518	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTEN—uterine cancer	2.81e-05	0.000518	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKR1B1—uterine cancer	2.78e-05	0.000513	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—STAR—uterine cancer	2.78e-05	0.000513	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—HRAS—uterine cancer	2.77e-05	0.00051	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.75e-05	0.000507	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—HRAS—uterine cancer	2.72e-05	0.000501	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—HRAS—uterine cancer	2.7e-05	0.000498	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—EP300—uterine cancer	2.68e-05	0.000494	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—EP300—uterine cancer	2.68e-05	0.000494	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—RRM2—uterine cancer	2.68e-05	0.000494	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—HRAS—uterine cancer	2.65e-05	0.000489	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—DCN—uterine cancer	2.6e-05	0.00048	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—POLD1—uterine cancer	2.59e-05	0.000478	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—POLD1—uterine cancer	2.54e-05	0.000468	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP11A1—uterine cancer	2.45e-05	0.000452	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKR1C1—uterine cancer	2.43e-05	0.000447	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKR1C1—uterine cancer	2.38e-05	0.000438	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—HRAS—uterine cancer	2.32e-05	0.000427	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AKR1C3—uterine cancer	2.31e-05	0.000427	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	2.21e-05	0.000408	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—POLD1—uterine cancer	2.18e-05	0.000402	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—RRM2—uterine cancer	2.16e-05	0.000399	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—RRM2—uterine cancer	2.12e-05	0.00039	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—DCN—uterine cancer	2.1e-05	0.000387	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.08e-05	0.000383	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.08e-05	0.000383	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—DCN—uterine cancer	2.06e-05	0.000379	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKR1C1—uterine cancer	2.04e-05	0.000376	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CA—uterine cancer	1.98e-05	0.000365	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CA—uterine cancer	1.98e-05	0.000365	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.98e-05	0.000365	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.94e-05	0.000357	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKR1C3—uterine cancer	1.87e-05	0.000344	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.83e-05	0.000337	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—RRM2—uterine cancer	1.82e-05	0.000336	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.8e-05	0.000332	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—STK11—uterine cancer	1.8e-05	0.000332	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—DCN—uterine cancer	1.77e-05	0.000326	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.73e-05	0.000319	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP11A1—uterine cancer	1.66e-05	0.000307	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AKT1—uterine cancer	1.62e-05	0.000299	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AKT1—uterine cancer	1.62e-05	0.000299	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKR1C3—uterine cancer	1.57e-05	0.00029	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—STAR—uterine cancer	1.5e-05	0.000277	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.5e-05	0.000277	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—STK11—uterine cancer	1.45e-05	0.000268	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP19A1—uterine cancer	1.45e-05	0.000268	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—STK11—uterine cancer	1.42e-05	0.000263	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP19A1—uterine cancer	1.42e-05	0.000263	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.41e-05	0.00026	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—MTHFR—uterine cancer	1.35e-05	0.00025	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—STK11—uterine cancer	1.22e-05	0.000226	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP19A1—uterine cancer	1.22e-05	0.000226	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—EP300—uterine cancer	1.2e-05	0.000222	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—POLD1—uterine cancer	1.18e-05	0.000217	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.15e-05	0.000212	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—VEGFA—uterine cancer	1.14e-05	0.00021	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—NRAS—uterine cancer	1.13e-05	0.000208	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.1e-05	0.000203	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.1e-05	0.000202	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—MTHFR—uterine cancer	1.09e-05	0.000202	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—MTHFR—uterine cancer	1.07e-05	0.000197	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—RRM2—uterine cancer	9.82e-06	0.000181	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—KRAS—uterine cancer	9.69e-06	0.000179	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—DCN—uterine cancer	9.54e-06	0.000176	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—MTHFR—uterine cancer	9.2e-06	0.00017	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP11A1—uterine cancer	8.98e-06	0.000166	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CA—uterine cancer	8.91e-06	0.000164	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—uterine cancer	8.62e-06	0.000159	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKR1C3—uterine cancer	8.48e-06	0.000156	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HRAS—uterine cancer	8.24e-06	0.000152	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.11e-06	0.00015	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTEN—uterine cancer	7.54e-06	0.000139	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—AKT1—uterine cancer	7.28e-06	0.000134	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—EP300—uterine cancer	7.19e-06	0.000133	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—STK11—uterine cancer	6.61e-06	0.000122	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP19A1—uterine cancer	6.61e-06	0.000122	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTEN—uterine cancer	6.08e-06	0.000112	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTEN—uterine cancer	5.96e-06	0.00011	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—EP300—uterine cancer	5.8e-06	0.000107	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—EP300—uterine cancer	5.68e-06	0.000105	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CA—uterine cancer	5.32e-06	9.8e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTEN—uterine cancer	5.12e-06	9.44e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MTHFR—uterine cancer	4.97e-06	9.16e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—EP300—uterine cancer	4.88e-06	9e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AKT1—uterine cancer	4.34e-06	8.01e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CA—uterine cancer	4.29e-06	7.91e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CA—uterine cancer	4.2e-06	7.75e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CA—uterine cancer	3.61e-06	6.66e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKT1—uterine cancer	3.5e-06	6.46e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKT1—uterine cancer	3.43e-06	6.33e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKT1—uterine cancer	2.95e-06	5.44e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTEN—uterine cancer	2.76e-06	5.09e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—EP300—uterine cancer	2.63e-06	4.86e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.95e-06	3.59e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKT1—uterine cancer	1.59e-06	2.94e-05	CbGpPWpGaD
